Researchers harness tumour cells to boost antitumour immunity in preclinical cancer models
Investigators from Mass General Brigham, USA, have developed a way to promote antitumour immunity by hijacking cellular…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
Breathomics: biosensor technology may lead to breath test for lung cancer
University of Texas at Dallas (USA) researchers have developed biosensor technology that, when combined with…
S3 E9 The Oncology Journal Club ESMO 2025 Special: Part 2
ESMO Special Part 2! Are you ready for ESMO Bingo? Welcome to Episode 9 of the third series of The Oncology Journal Club. Dr Kate Clarke takes over hosting duties as Professor Craig Underhill unpacks the GU and lung highlights. With witty commentary and a London Global Cancer Week sneak preview by Professor Christopher Jackson.
Breast Cancer Index may help guide adjuvant endocrine therapy in premenopausal women
New data from the Tamoxifen and Exemestane Trial (TEXT) suggest that the Breast Cancer Index…
Risky behaviour: Most Americans unaware of alcohol–cancer link
Despite decades of evidence showing alcohol as a known carcinogen, the majority of U.S. adults…
The role of WNT signaling in cancer: from mechanisms to therapeutics
The WNT signalling pathway, an evolutionarily conserved system crucial for tissue development and repair, is…
UK study aiming for earlier detection of lung cancers
A new study, which has recently begun recruiting, is hoped to lead to earlier detection…
Outdoor air pollution linked to higher incidence of breast cancer
Women living in parts of the United States with lower air quality, especially neighbourhoods with…
Australian researchers uncover new driver of ovarian cancer spread
Adelaide researchers have identified a promising new biomarker and treatment target for ovarian cancer that…
Lenalidomide promotes melarsoprol-activated cGAS-STING-mediated immunotherapy for hepatocellular carcinoma
Hepatocellular carcinoma (HCC), the most common primary liver cancer, poses a global health threat with…